Skip to main navigation

Top Navigation

Publications
Newsroom
Investors
Blog
Careers
Contact Us

mRNA Technology
Modalities
Pipeline
- Clinical Trials
- Therapeutic Areas
Ecosystem
- Strategic Collaborators
- New Venture Labs
About Us

Investors

IR Navigation

Overview
Stock Information
Corporate Governance
SEC Filings
Events & Presentations
Press Releases
Shareholder Resources

Investor Relations

Day High

Day Low

Volume

12:59 PM EST
January 22, 2020

Copyright West LLC.
Minimum 15 minutes Delayed.

Press Releases

January 12, 2020

Moderna Builds on Clinical Validation of Systemic Delivery with Two Additional Development Candidates in New Autoimmune Therapeutic Area

January 9, 2020

Moderna Announces Additional Positive Phase 1 Data from Cytomegalovirus (CMV) Vaccine (mRNA-1647) and First Participant Dosed in Phase 2 Study

January 6, 2020

Moderna to Provide Business and Pipeline Updates at the 2020 J.P. Morgan Healthcare Conference

View All Press Releases

Events

No events are currently scheduled.

View All Events

Presentations

Corporate Presentation

Moderna 2019 R&D Day Presentation

Pipeline Program Detail

IR Contact

IR@modernatx.com

Email Alerts

Click Here to have company news delivered to your inbox

mRNA Technology
Modalities
Pipeline
Ecosystem
About Us

Publications
Newsroom
Investors
Blog
Careers
Contact Us

Facebook
Twitter
Youtube
LinkedIn

Footer Menu - Bottom

© 2020 Moderna, Inc.
Privacy Policy
Join our Mailing List
Terms of Use

×

You are now leaving investors.modernatx.com, a website provided by Moderna. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. The content displayed on external websites is not controlled by Moderna, and Moderna assumes no responsibility for the information or statements on such external websites.